Tim Illidge

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Mick Brown

The University of Manchester

UNITED KINGDOM

View details

Mark Travis

Professor of Immunology

University of Manchester

UNITED KINGDOM

View details

Sally Barrington

King’s College London

UNITED KINGDOM

View details

Debayan Mukherjee

The University of Manchester

UNITED KINGDOM

View details

Claire Alexandra Hart

The University of Manchester

UNITED KINGDOM

View details

Peter Hoskin

The University of Manchester

UNITED KINGDOM

View details

Hitesh Mistry

The University of Manchester

UNITED KINGDOM

View details

Douglas Dyer

The University of Manchester

UNITED KINGDOM

View details

Graham McIlroy

NIHR Academic Clinical Lecturer in Haematology

University of Birmingham

UNITED KINGDOM

View details

Elizabeth Phillips

The University of Manchester

UNITED KINGDOM

View details

Urszula Cytlak

The University of Manchester

UNITED KINGDOM

View details

Andrea Kuhnl

King's College Hospital

UNITED KINGDOM

View details

Lucy Cook

Honorary Senior Clinical Lecturer

Imperial College London

UNITED KINGDOM

View details

Christopher Paul Fox

Clinical Professor of Haematology

University of Nottingham

UNITED KINGDOM

View details

Catharine West

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tim Illidge

Research Interests

Explore related searches

Contact this professor

Articles (15)

Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study

The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline

Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer

Relapse patterns in early‐PET negative, limited‐stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy–a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials

A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom

Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies

IRF7 impacts on prostate cancer cell survival in response to radiation

Immunomodulation by radiotherapy in tumour control and normal tissue toxicity

Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer

Guidelines for the management of mature T‐ and natural killer‐cell lymphomas (excluding cutaneous T‐cell lymphoma): a British Society for Haematology Guideline

The ECHELON-2 Trial

Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries

The effect of hypoxia on PD-L1 expression in bladder cancer

Progress and pitfalls with the use of image-guided personalised approaches in lymphoma

Collaborators (15)

Mick Brown

Mark Travis

Sally Barrington

Debayan Mukherjee

Claire Alexandra Hart

Peter Hoskin

Hitesh Mistry

Douglas Dyer

Graham McIlroy

Elizabeth Phillips

Urszula Cytlak

Andrea Kuhnl

Lucy Cook

Christopher Paul Fox

Catharine West

Make your next move.